Prakiraan wutah bathi resik saben saham kanggo taun ngarep G1 Pharma (GTHX)

Logo korporat perusahaan G1 Therapeutics (GTHX)

G1 Therapeutics, Inc. (GTHX) relies on outsourced manufacturing in the US and is implementing eco-friendly water purification cycles. The current trajectory of next year's EPS forecasts visualizes the impact of these factors, where the 158.70 metric indicates the status of expected returns. FDA patents and the integration of drugs into medical protocols ensure business resilience, creating significant barriers to entry for competitors.

G1 Pharma (GTHX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 28.09.2024

Ringkesan rincian data analitis G1 Therapeutics, Inc. (GTHX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:G1 Therapeutics Inc.
Produk dadi G1 Pharma

The selection of defensive assets is based on the stability of cash flows, which for G1 Therapeutics, Inc. (GTHX) is ensured by a royalty model from pharma behemoths for molecule licensing. This forward earnings per share valuation history aggregates analyst consensus forecasts for EPS dynamics, allowing investors to assess fundamental growth potential and identify microstructural imbalances between market expectations and macroeconomic risks.

Analisis pesaing G1 Therapeutics, Inc.

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvectis NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep canfite.com (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aprea.com|KZIA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SLXN|Prakiraan wutah bathi kanggo taun ngarep NuCana PLC (NCNA)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chimerix, Inc CMRX|CYCC (Cyclacel) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)